RWA Wealth Partners’s MiMedx Group MDXG Stock Holding History

RWA Wealth Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,000	Closed	-$51K	–	522
2018 Q2	$51K	Buy	+8,000	New	+$56.9K	0.01%	406

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

RWA Wealth Partners's MDXG Position: Q3 2018 in Review

RWA Wealth Partners sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 8,000 shares — an estimated $51K sold.

RWA Wealth Partners first reported a position in MDXG in Q2 2018 and held it in 1 quarter. The position peaked at $51K in Q2 2018. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

RWA Wealth Partners reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
RWA Wealth Partners sold 8,000 MiMedx Group shares in Q3 2018, an estimated $51K.
RWA Wealth Partners first reported a position in MiMedx Group in Q2 2018 and held it in 1 quarter.
RWA Wealth Partners's MiMedx Group position peaked at $51K in Q2 2018.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on RWA Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.